749
Views
180
CrossRef citations to date
0
Altmetric
Research Article

Economic impact and quality-of-life burden of allergic rhinitis

, , , &
Pages 305-317 | Accepted 20 Nov 2004, Published online: 31 Dec 2004

References

  • Dykewicz MS, Fineman S. Diagnosis and management of rhinitis: parameter documents of the Joint Task Force on Practice Parameters in Allergy, Asthma, & Immunology. Executive Summary of the Joint Task Force on Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 1998;81(Suppl):463–68
  • Galant SP, Wilkinson R. Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options? BioDrugs 2001;15:453–63
  • Ricketti AJ. Allergic rhinitis. In: Grammer LC, Greenberg PA, eds. Patterson’s Allergic Diseases. 6th edn. Philadelphia: Lippincott Williams & Wilkins;2002:159–82
  • Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22–7
  • Fireman P. Rhinitis and asthma connection: management of coexisting upper airway allergic diseases and asthma. Allergy Asthma Proc 2000;21:45–54
  • Hewitt Associates LLC. Allergy costs may cause watery eyes for employers. Managing Health and Business Productivity [online]. Available from http://was.hewitt.com/hewitt/business/healthmgt/subhealth/hlbus_allergies.htm [Accessed May 15, 2001]
  • Blaiss M. Costs of allergic rhinitis. In: Kaliner MA, ed. Current Review of Rhinitis. Philadelphia: Current Medicine, 2002
  • Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82:233–48
  • Siegel C. The widespread disorder that gets no respect [online]. Presented at the Annual Meeting of the American College of Allergy, Asthma & Immunology; November 12, 1999. Available from http://www.medscape.com/medscape/cno/1999/ACAAI/Story.cfm?story_id=881 [Accessed Apr 22, 2001]
  • Nathan RA, Meltzer EO, Selner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:S808–14
  • Platts-Mills TA, Carter MC, Heymann PW. Specific and nonspecific obstructive lung disease in childhood: causes of changes in the prevalence of asthma. Environ Health Perspect 2000;108\(Suppl 4):725–31
  • Marshall AH, Owen V, Jones NS. More siblings, less hay fever: more evidence. Clin Otolaryngol 2002;27:352–8
  • Ring J, Kramer U, Schafer T, Abeck D, Vieluf D, Behrendt H. Environmental risk factors for respiratory and skin atopy: results from epidemiological studies in former East and West Germany. Int Arch Allergy Immunol 1999;118 (Pt 4):403–7
  • von Mutius E, Braun-Fahrlander C, Schierl R, et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000;30:1230–4
  • Braun-Fahrländer CH, Gassner M, Grize L, et al. Prevalence of hay fever and allergic sensitization in farmer’s children and their peers living in the same rural community. Clin Exp Allergy 1999;29:28–34
  • von Ehrenstein O, von Mutius E, Illi S, Baumann L, Böhm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000;30:187–93
  • Riedler J, Eder W, Oberfeld G, Schreuer M. Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 2000;30:194–200
  • Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989;19:59–63
  • Nicolai T, Illi S, von Mutius E. Effect of dampness at home in childhood on bronchial hyperreactivity in adolescence. Thorax 1998;53:1035–40
  • Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209–13
  • Greisner WA III, Settipane RJ, Settipane GA. Coexistence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19: 185–8
  • Bernstein J, Lee J, Conboy K, Ellis E, Li P. Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion. Otolaryngol Head Neck Surg 1985;93:611–5
  • Berrettini S, Carabelli A, Sellari-Francheschini S, Bruschini L, Abruzzese A, Quartieri F, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy 1999;54:242–8
  • Tomonaga K, Kurono Y, Mogi G. The role of nasal allergy in otitis media with effusion: a clinical study. Acta Otolaryngol 1988;458(Suppl):S41–7
  • Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis: a review of 6,037 patients. J Allergy Clin Immunol 1977;59:17–21
  • Farrell BP. Endoscopic sinus surgery: sinonasal polyposis and allergy. Ear Nose Throat J 1993;72:544–59
  • Bousquet J, van Cauwenberge P, Khaltaev N, for the ARIA Workshop/World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147–336
  • American Academy of Allergy, Asthma and Immunology (AAAAI). Allergic Disorders: Promoting Best Practices – The Allergy Report. 2000 [online]. Available from http://theallergyreport.com/http://TheAllergyReport.com [Accessed Mar 30, 2001]
  • Simons FER. Allergic rhinobronchitis: the asthma–allergic rhinitis link. J Allergy Clin Immunol 1999;104:534–40
  • Montnemery P, Svensson C, Adelroth E, Lofdahl CG, Andersson M, Greiff L, et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001;17:596–603
  • Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma: a population-based study of young adults. Am J Respir Crit Care Med 2000;162:1391–6
  • Majani G, Baiardini I, Giardini A, Senna GE, Minale P, D’Ulisse S, et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001;56:313–7
  • Corey JP, Kemker BJ, Branca JT, Kuo F, Chang Y, Gliklich RE. Health status in allergic rhinitis. Otolaryngol Head Neck Surg 2000;122:681–5
  • Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998;7:693–702
  • Leong KP, Chan SP, Tang CY, Yeak SC, Saurajen AS, Mok PK, et al. Quality of life of patients with perennial allergic rhinitis: preliminary validation of the Rhinoconjunctivitis Quality of Life Questionnaire in Singapore. Asian Pac J Allergy Immunol 1999;17:163–7
  • Senior BA, Glaze C, Benninger MS. Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease. Am J Rhinol 2001;15:15–20
  • Ferrans CE. Development of a conceptual model of quality of life. Sch Inq Nurs Pract 1996;10:293–304
  • Annett RD. Assessment of health status and quality of life outcomes for children with asthma. J Allergy Clin Immunol 2001;107:S473–81
  • Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol 1999;103:401–7
  • Fireman P. Treatment of allergic rhinitis: effect on occupation productivity and work force costs. Allergy Asthma Proc 1997;18:63–7
  • Bagenstose SE, Bernstein JA. Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes. Ann Allergy Asthma Immunol 1999;83:524–8
  • Young T, Finn L, Kim H, for the University of Wisconsin Sleep and Respiratory Research Group. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol 1997;99:S757–62
  • Diette GB, Markson L, Skinner EA, Nguyen TT, Algatt-Bergstrom P, Wu AW. Nocturnal asthma in children affects school attendance, school performance, and parents’ work attendance. Arch Pediatr Adolesc Med 2000;154:923–8
  • Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 2000;105:S622–7
  • Seidel WF, Cohen S, Bliwise NG, Dement WC. Direct measurement of daytime sleepiness after administration of ceritizine and hydroxyzine with a standardized electroencephalographic assessment. J Allergy Clin Immunol 1990;86:1029–33
  • Goetz DW, Jacobson JM, Murnane JE, Reid MJ, Repperger DW, Goodyear C, et al. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol 1989;84:316–22
  • Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. Loss of work productivity due to illness and medical treatment. J Occup Environ Med 1999;41:948–53
  • Kay GG, Plotkin KE, Quig MB, Starbuck VN, Yasuda S. Sedating effects of AM/PM antihistamine dosing with evening chlorpheniramine and morning terfenadine. Am J Man Care 1997;3:1843–8
  • Ross RN. The cost of allergic rhinitis. Am J Man Care 1996;2:285–90
  • Gilmore TM, Alexander BH, Mueller BA, Rivera FP. Occupational injuries and medical use. Am J Ind Med 1996;30:234–49
  • Simons FER, Simons RER, eds. Histamine & H1-Antihistamine in Allergic Disease. New York, NY; Marcel Dekker, Inc: 2002
  • Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001;54:610–8
  • Hewitt Associates LLC. Survey on future health care expectations [online]. Available from http://was.hewitt.com/hewitt/resource/rptspubs/subrptspubs/survey index.htm [Accessed Jun 14, 2001]
  • Nash DB, Sullivan SD, Mackowiak J. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting. Am J Man Care 2000;6(Suppl 1):S3–15
  • American Academy of Family Physicians (AAFP). Facts About Family Practice – 1999 [online]. Available at http: //www.aafp.org/facts/ (Tables 17, 18, 22). [Accessed March 29, 2001]
  • Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:3–8
  • Lee J, Cummins G, Okamoto L. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis. Am J Manag Care 2001;7(Suppl):S103–12
  • Stempel DA, Woolf R. The cost of treating allergic rhinitis. Curr Allergy Asthma Rep 2002;2:223–30
  • Weir E. The burden of rhinitis: nothing to sniff at. CMAJ 2003;169:694
  • Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis. Evidence Report/Technology Assessment No. 54. Washington: The Agency; 2002. Available at http://www.ahrq.gov/clinic/epcsums/rhinsum.htm. [Accessed October 15, 2003]
  • Ratner PH, Ehrlich PM, Fineman SM, Meltzer EO, Skoner DP. Use of intranasal cromolyn sodium for allergic rhinitis. May Clin Proc 2002;77:350–4
  • Rachelfsky GS. National guidelines needed to manage rhinitis and prevent complications. Ann Allergy Asthma Immunol 1999;82:296–305
  • Allergy, Asthma & Immunology online. FDA requires new pediatric labeling for inhaled, intranasal corticosteroids: asthma specialists urge patients not to stop using medications without speaking to their physicians. Available at www.allergy.mcg.edu/ news/cspts.html. [Accessed February 20, 2002]
  • Skoner DP, Rachelfsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:E23
  • Dupclay L Jr, Doyle J. Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences. Am J Manag Care 2002;8:S335–40
  • Schenkel EJ, Skoner DP, Bronsky EA, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:E22
  • Law AW, Reed SD, Sundy JS, Schulman KA. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol 2003;111:296–300
  • Handelman NI, Friday GA, Schwartz HJ, et al. Cromolyn sodium nasal solution in the prophylactic treatment of pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 1977;59:237–42
  • Welsh PW, Yuninger JW, Kern EB, Gleich GJ. Preseasonal IgE ragweed antibody level as a predictor of response to therapy of ragweed hay fever with intranasal cromolyn sodium solution. J Allergy Clin Immunol 1977;60:104–9
  • Chandra RK, Heresi G, Woodford G. Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis. Ann Allergy 1982;49: 131–4
  • Cohan RH, Bloom FL, Rhoades RB, Wittig HJ, Haugh LD. Treatment of perennial allergic rhinitis with cromolyn sodium: double-blind study on 34 adult patients. J Allergy Clin Immunol 1976;58: 121–8
  • Law AW, Reed SD, Schulman KA. Costs of allergic rhinitis in the United States. In: Program and Posters of the Seventh Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 19–22, 2002; Crystal City, Arlington, Virginia. Poster 502 [online]. Available at http://www.ispor.org/meetings/va0502/presentations/session1/PAR3.pdf [Accessed October 21, 2003]
  • Berger WE. Pharmacoeconomics and quality-of-life parameters in rhinitis. Rhinitis – Present Challenges and Treatments for the Future. Program and abstracts of the 1999 Annual Meeting of the American College of Allergy, Asthma and Immunology, November 12–17, 1999, Chicago, Illinois
  • Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000;6:373–8
  • Skoner DP. The interplay between otitis media and rhinitis in children [online]. Available at http://www.medscape.com/Medscape/RespiratoryCare/journal/1998/v02.n02/mrc3024.skon/mrc3024.skon.html [Accessed May 25, 2001]
  • DuBuske LM. The link between allergy and asthma. Allergy Asthma Proc 1999;20:341–5
  • Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, Harris AG. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999;102:54–9
  • Townley RG, Kiboneka A. Allergic rhinitis: relationship to asthma – similarities, differences, and interactions. Ann Allergy Asthma Immunol 1998;80:137–9
  • Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis. Evidence Report/Technology Assessment No. 67. Washington: The Agency; 2003. Available at http://www.ahrq.gov/clinic/epcsums/rhinworksum.htm. [Accessed October 15, 2003]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.